Reduced β-cell compensation to the insulin resistance associated with obesity in members of caucasian familial type 2 diabetic kindreds

Diabetes Care

Volumn 23, Issue 2, 2000, Pages 221-227

  Elbein, Steven C ^a,b,d   Wegner, Kimberly ^a,b   Kahn, Steven E ^c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; TOLBUTAMIDE;

ADULT; ARTICLE; CALCULATION; CONTROLLED STUDY; FAMILY HISTORY; FAMILY STUDY; GENETIC PREDISPOSITION; GLUCOSE INTOLERANCE; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL;

EID: 0033960006     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.23.2.221     Document Type: Article

References (32)

1. DeFronzo RA, Bonadonna RC, Ferrannini E: Pathogenesis of NIDDM: a balanced overview. Diabetes Care 15:318-368, 1992
2. Warram JH, Martin BC, Krolewski AS: Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 113:909-915, 1990
3. Martin BC, Warram JH, Rosner B, Rich SS, Soeldner JS, Krolewski AS: Familial clustering of insulin sensitivity. Diabetes 41: 850-854, 1992
4. Bogardus C, Lillioja S, Nyomba BL, Zurlo F, Swinburn B, Puente E-D, Knowler WC, Ravussin E, Mott DM, Bennett PH: Distribution of in vivo insulin action in Pima Indians as a mixture of three normal distributions. Diabetes 38:1423-1432, 1989
5. Sakul H, Pratley R, Cardon L, Ravussin E, Mott D, Bogardus C: Familiality of physical and metabolic characteristics that predict the development of non-insulin-dependent diabetes mellitus in Pima Indians. Am J Hum Genet 60:651-656, 1997
6. Schumacher MC, Hasstedt SJ, Hunt SC, Williams RR, Elbein SC: Major gene effect for insulin levels in familial NIDDM pedigrees. Diabetes 41:416-423, 1992
7. Elbein SC, Hasstedt SJ, Wegner K, Kahn SE: Heritability of pancreatic β-cell function among nondiabetic members of Caucasian familial type 2 diabetes kindreds. J Clin Endocrinol Metab 84:1398-1403, 1999
8. Pimenta W, Korytkowski M, Mitrakou A, Jenssen T, Yki-Jarvinen H, Evron W, Dailey G, Gerich J: Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM: evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. JAMA 273:1851-1861, 1993
9. Vaag A, Henriksen JE, Madsbad S, Holm N, Beck-Nielsen H: Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus. J Clin Invest 95:690-698, 1995
10. O'Rahilly SP, Rudenski AS, Burnett MA, Nugent Z, Hosker JP, Darling P, Turner RC: Beta-cell dysfunction, rather than insulin insensitivity, is the primary defect in familial type 2 diabetes. Lancet ii:360-364, 1986
11. Bergman RN, Phillips SP, Cobelli C: Physiologic evaluation of factors controlling glucose tolerance in man. J Clin Invest 68: 1456-1467, 1981
12. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP, Porte D Jr: Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects: evidence for a hyperbolic function. Diabetes 42: 1663-1672, 1993
13. Caro JF: Insulin resistance in obese and nonobese man. J Clin Endocrinol Metab 73: 691-695, 1991
14. Campbell PJ, Gerich JE: Impact of obesity on insulin action in volunteers with normal glucose tolerance: demonstration of a threshold for the adverse effect of obesity. J Clin Endocrinol Metab 70:1114-1118, 1990
15. Ferrannim E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G: Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Invest 100:1166-1173, 1997
16. Ishikawa M, Pruneda ML, Adams-Huet B, Raskin P: Obesity-independent hyperinsulinemia in nondiabetic first-degree relatives of individuals with type 2 diabetes. Diabetes 47:788-792, 1998
17. Harris MI, Hadden WC, Knowler WC, Bennett PH: International criteria for the diagnosis of diabetes and impaired glucose tolerance. Diabetes Care 8:562-567, 1985
18. Raffel LJ, Robbins DC, Norris JM, Boerwinkle E, DeFronzo RA, Elbein SC, Fujimoto W, Hanis CL, Kahn SE, Permutt MA, Chiu KC, Cruz J, Ehrmann DA, Robertson RP, Rotter JI, Buse J: The GENNID Study: a resource for mapping the genes that cause NIDDM. Diabetes Care 19:864-872, 1996
19. Prigeon RL, Kahn SE, ADA GENNID Study Group: Validation of a 25-sample tolbutamide-modified intravenous glucose tolerance test to phenotype subjects for genetic studies of NIDDM. Diabetes 46 (Suppl. 1): 138A-138A, 1997
20. Pacini G, Bergman RN: MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 23:113-122, 1986
21. Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C, Groop L: Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321:337-343, 1989
22. Vaag A, Henriksen JE, Beck Nielsen H: Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin dependent diabetes mellitus. J Clin Invest 89:782-788, 1992
23. Lillioja S, Mott DM, Zawadzki JK, Young AA, Abbot WGH, Knowler WC, Bennett PH, Moll P, Bogardus C: In vivo insulin action is familial characteristic in nondiabetic Pima Indians. Diabetes 36:1329-1335, 1987
24. Beck Nielsen H, Henriksen JE, Alford F, Hother-Nielson O: In vivo glucose metabolism, insulin secretion, and insulin action in Europids with non-insulin dependent diabetes mellitus (NIDDM) and their first degree relatives. Diabet Med 13:S78-S84, 1996
25. Dunaif A, Finegood DT: β-Cell dysfunction independent of obesity and glucose intolerance in polycystic ovary syndrome. J Clin Endocrinol Metab 81:942-947, 1996
26. Kulkarni RN, Wang ZL, Wang RM, Hurley JD, Smith DM, Ghatei MA, Withers DJ, Gardiner JV, Bailey CJ, Bloom SR: Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J Clin Invest 100:2729-2736, 1997
27. + channels in pancreatic beta-cells. Diabetes 46:1087-1093, 1997
28. Emilsson V, Liu YL, Cawthorne MA, Morton NM, Davenport M: Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leplm on insulin secretion. Diabetes 46: 313-316, 1997
29. Shimabukuro M, Zhou YT, Levi M, Unger RH: Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci U S A 95:2498-2502, 1998
30. Byrne MM, Sturis J, Sobel RJ, Polonsky KS: Elevated plasma glucose 2 h postchallenge predicts defects in β-cell function. Am J Physiol 270:E572-E579, 1996
31. Cavaghan MK, Ehrmann DA, Byrne MM, Polonsky KS: Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance. J Clin Invest 100:530-537, 1997
32. Ehrmann DA, Schneider DJ, Sobel BE, Cavaghan MK, Imperial J, Rosenfield RL, Polonsky KS: Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 82:2108-2116, 1997